Notes
2018 US dollars
Reference
Wang CY, et al. Updating the Cost Effectiveness of Oral Anticoagulants for Patients with Atrial Fibrillation Based on Varying Stroke and Bleed Risk Profiles. PharmacoEconomics : 14 Sep 2020. Available from: URL: http://doi.org/10.1007/s40273-020-00960-0
Rights and permissions
About this article
Cite this article
Dabigatran cost effective in AF but stroke and bleeding risk important. PharmacoEcon Outcomes News 863, 10 (2020). https://doi.org/10.1007/s40274-020-7164-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7164-z